This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB02049/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB02049/identifier/pubchem-compound/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://linked.opendata.cz/resource/drugbank/drug/DB02049/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02049/identifier/drugbank/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB02049/identifier/chemspider/

Statements

Subject Item
n2:DB02049
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n13:DB02049 n14:DB02049
dcterms:title
2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide
adms:identifier
n6:46508760 n7:CBP n8:5111 n9:4931 n11:DB02049
n3:IUPAC-Name
n4:271B5FEA-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5FF0-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5FEF-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5FEC-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5FED-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5FEE-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5FE8-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5FE9-363D-11E5-9242-09173F13E4C5 n4:271B5FE6-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5FE7-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5FF6-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5FF7-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5FF1-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5FF2-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5FF4-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5FF3-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5FF5-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5FFC-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5FFE-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5FFF-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5FFB-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5FFA-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5FFD-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5FEB-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5FF8-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5FF9-363D-11E5-9242-09173F13E4C5